Retatrutide 30mg – Research Peptide

Retatrutide 30mg – Research Peptide

Product Overview

Retatrutide is an investigational synthetic peptide that acts as a triple receptor agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.

It is being studied in clinical and laboratory research involving metabolic regulation, energy expenditure, and glucose homeostasis.

Research Applications

Retatrutide is investigated in research related to:

• GLP-1, GIP, and glucagon receptor signaling
• Metabolic regulation
• Glucose homeostasis
• Energy balance and expenditure
• Receptor-mediated metabolic pathways

Product Specifications

• Product Name: Retatrutide
• Peptide Content: 30 mg per vial
• Physical Form: Lyophilized powder
• Purity: Refer to the batch-specific Certificate of Analysis
• Storage: Follow the validated storage conditions provided with the product

Research Use Disclaimer

This product is intended strictly for legitimate laboratory research purposes.

Not for human or veterinary use. Not intended for ingestion, injection, or therapeutic applications.

Retatrutide is an investigational compound and is not approved for general clinical use.